Related Experiment Video

Updated: Jun 13, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

Preventing stroke in hypertensive patients at risk

Björn Dahlöf1

  • 1Department of Medicine, Sahlgrenska University Hospital/Ostra, Gothenburg, Sweden.

Journal of the American Society of Hypertension : JASH
|April 23, 2010
PubMed

Insights

High blood pressure significantly increases stroke risk. Certain medications like telmisartan may offer additional stroke protection beyond blood pressure reduction alone, aiding secondary stroke prevention.

Area of Science:

  • Cardiology
  • Neurology
  • Pharmacology

Background:

  • Stroke remains a leading cause of death and disability globally, with rising incidence despite healthcare advances.
  • Elevated blood pressure (BP) is the primary modifiable risk factor for stroke, significantly increasing risk.
  • Current antihypertensive treatments show variable efficacy in stroke prevention, even with similar BP reductions.

Purpose of the Study:

  • To investigate the role of angiotensin receptor blockers (ARBs), specifically telmisartan, in stroke prevention.
  • To evaluate the additional cardiovascular benefits of telmisartan beyond BP reduction.
  • To assess telmisartan's efficacy in secondary stroke prevention through large-scale trials like PRoFESS.

Main Methods:

  • Analysis of large-scale clinical trials, including the Prevention Regimen For Effectively avoiding Second Strokes (PRoFESS) trial.
  • Comparison of stroke prevention efficacy across different antihypertensive drug classes.
  • Evaluation of telmisartan's specific properties in cardiovascular outcome studies.

Main Results:

  • Angiotensin receptor blockers (ARBs) demonstrate protective effects against stroke and cardiovascular events beyond BP lowering.
  • Telmisartan is under investigation for its potential to offer enhanced stroke prevention.
  • The PRoFESS trial is crucial for understanding telmisartan's role in secondary stroke prevention.

Conclusions:

  • Telmisartan shows promise for superior stroke prevention compared to other antihypertensives.
  • Further results from trials like PRoFESS are needed to confirm telmisartan's benefits in secondary stroke prevention.
  • Optimizing stroke recurrence prevention in high-risk patients may involve agents with pleiotropic effects like telmisartan.

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...